Featured Research

from universities, journals, and other organizations

New clues in hunt for heredity in type 2 diabetes

Date:
March 19, 2013
Source:
Lund University
Summary:
Type 2 diabetes has strong hereditary tendencies and the genes we are born with cannot be changed. However, new research shows that we can modify the function of the genes through the epigenetic changes that take place in the course of life.

Type 2 diabetes has strong hereditary tendencies and the genes we are born with cannot be changed. However, new research from Lund University in Sweden shows that we can modify the function of the genes through the epigenetic changes that take place in the course of life.

Epigenetic changes are usually described as a link between heredity and environment and come about as a result of factors such as aging, chemicals, medication, diet, exercise and drugs.

Researchers have now demonstrated that half of the known genetic risk variants for type 2 diabetes can be influenced by epigenetic changes that in turn influence the function of the insulin-producing cells.

"This means that we gain a tool to influence the function of the risk genes, improve insulin release and thereby reduce the risk of diabetes," says Charlotte Ling at Lund University Diabetes Centre, who has today published a study on epigenetic effects in connection with type 2 diabetes in the journal Diabetologia.

The epigenetic factor that has been studied is a chemical change on the DNA strand following a certain pattern, known as DNA methylation.

"We have shown that 19 of 40 known genetic risk variants for type 2 diabetes are affected by DNA methylation, which in turn changes the function of the insulin-producing cells," says Charlotte Ling. "This is important. Many researchers have put a lot of time and resources into mapping our genome and finding genetic risk markers for diabetes and other diseases. We know that there are genetic variants that increase the risk of type 2 diabetes, but in most cases the reasons why this happens are still not known. The next step is to find this out and after this study of the genetic risk variants, we can say that in some cases the increased risk is probably due to varying degrees of DNA methylation."

The research group has studied insulin-producing cells from 84 deceased donors. This is the first epigenetic study to be carried out on the 40 risk markers for type 2 diabetes.

The present study shows that DNA methylation of genetic risk variants for diabetes influence the insulin-producing cells in various different ways, such as the amount of insulin they contain and the amount they are able to release into the blood stream. "The next step in our work is to test whether we can reduce the risk of type 2 diabetes by changing the degree of DNA methylation in the genetic risk variants for the disease."


Story Source:

The above story is based on materials provided by Lund University. Note: Materials may be edited for content and length.


Journal Reference:

  1. T. A. Dayeh, A. H. Olsson, P. Volkov, P. Almgren, T. Rönn, C. Ling. Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia, 2013; DOI: 10.1007/s00125-012-2815-7

Cite This Page:

Lund University. "New clues in hunt for heredity in type 2 diabetes." ScienceDaily. ScienceDaily, 19 March 2013. <www.sciencedaily.com/releases/2013/03/130319091144.htm>.
Lund University. (2013, March 19). New clues in hunt for heredity in type 2 diabetes. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2013/03/130319091144.htm
Lund University. "New clues in hunt for heredity in type 2 diabetes." ScienceDaily. www.sciencedaily.com/releases/2013/03/130319091144.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) — An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) — Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) — Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) — It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins